Reviews in Endocrine and Metabolic Disorders

, Volume 9, Issue 4, pp 267–274

Defining human diabetic nephropathy on the molecular level: Integration of transcriptomic profiles with biological knowledge

Authors

  • Sebastian Martini
    • Division of Nephrology, Department of Internal MedicineUniversity of Michigan
  • Felix Eichinger
    • Division of Nephrology, Department of Internal MedicineUniversity of Michigan
  • Viji Nair
    • Division of Nephrology, Department of Internal MedicineUniversity of Michigan
    • Division of Nephrology, Department of Internal MedicineUniversity of Michigan
Article

DOI: 10.1007/s11154-008-9103-3

Cite this article as:
Martini, S., Eichinger, F., Nair, V. et al. Rev Endocr Metab Disord (2008) 9: 267. doi:10.1007/s11154-008-9103-3

Abstract

Diabetic nephropathy (DN) is the most common cause for end stage renal disease (ESRD). Next to environmental factors, genetic predispositions determine the susceptibility for DN and its rate of progression to ESRD. With the availability of genome wide expression profiling we have the opportunity to define relevant pathways activated in the individual diabetic patient, integrating both environmental exposure and genetic background. In this review we summarize current understanding of how to link comprehensive gene expression data sets with biomedical knowledge and present strategies to build a transcriptional network of DN. Information about the individual disease processes of DN might allow the implementation of a personalized molecular medicine approach with mechanism-based patient management. Web based search engines like Nephromine are essential tools to facilitate access to molecular data of genomics, proteomics and metabolomics of DN.

Keywords

Diabetic nephropathyPersonalized molecular medicinePatient tailored medicineGene expressionTranscription regulatory networks

Copyright information

© Springer Science+Business Media, LLC 2008